A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.

Schmid P, KГјhnhardt D, Kiewe P, Lehenbauer-Dehm S, Schippinger W, Greil R, Lange W, Preiss J, Niederle N, Brossart P, Freier W, KГјmmel S, Van de Velde H, Regierer A, Possinger K.

http://www.ncbi.nlm.nih.gov/pubmed/18209010